Your browser doesn't support javascript.
loading
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
Pauwels, Renske W M; Proietti, Elisa; van der Woude, Christien J; Oudijk, Lindsey; Crombag, Marie-Rose B S; Peppelenbosch, Maikel P; Grohmann, Ursula; Fuhler, Gwenny M; de Vries, Annemarie C.
  • Pauwels RWM; Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
  • Proietti E; Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
  • van der Woude CJ; University of Perugia, Department of Experimental Medicine, Perugia, Italy.
  • Oudijk L; Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
  • Crombag MBS; Erasmus MC, Department of Pathology, Rotterdam, the Netherlands.
  • Peppelenbosch MP; Erasmus MC, Department of Hospital Pharmacy, Rotterdam, the Netherlands.
  • Grohmann U; Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
  • Fuhler GM; University of Perugia, Department of Experimental Medicine, Perugia, Italy.
  • de Vries AC; Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
Inflamm Bowel Dis ; 27(11): 1813-1820, 2021 10 20.
Article en En | MEDLINE | ID: mdl-33705545

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article